Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes- The Best Cell phone Brands for Tech Lovers
- South African army arrive in crime hotspots to help tackle gangs
- 6 Eyewear Brands Worth Purchasing
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- Poll: 62% of Americans would oppose U.S. military action in Greenland
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Vote in favor of the juice that you love for its medical advantages!
- 'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say
